Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
- 15 June 2016
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 138 (S1), 54-70
- https://doi.org/10.1111/jnc.13588
Abstract
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The past decade has seen the discovery of several new FTD-causing genetic mutations and the identification of many of the relevant pathological proteins. The current neuropathological classification is based on the predominant protein abnormality and allows most cases of FTD to be placed into one of three broad molecular subgroups; frontotemporal lobar degeneration with tau, TDP-43 or FET protein accumulation. This review will describe our current understanding of the molecular basis of FTD, focusing on insights gained from the study of human postmortem tissue, as well as some of the current controversies. Most cases of FTD can be subclassified into one of three broad molecular subgroups based on the predominant protein that accumulates as pathological cellular inclusions. Understanding the associated pathogenic mechanisms and recognizing these FTD molecular subtypes in vivo will likely be crucial for the development and use of targeted therapies. This article is part of the Frontotemporal Dementia special issue.Keywords
Funding Information
- Canadian Institutes of Health Research
This publication has 101 references indexed in Scilit:
- Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2009
- Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypesActa Neuropathologica, 2009
- Clinical and Pathological Continuum of Multisystem TDP-43 ProteinopathiesArchives of Neurology, 2009
- Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathiesActa Neuropathologica, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Alzheimer and frontotemporal pathology in subsets of primary progressive aphasiaAnnals of Neurology, 2008
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Frontotemporal dementia: Clinicopathological correlationsAnnals of Neurology, 2006
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991